BR112015022692A2 - método para a preparação de ticagrelor, e, composto - Google Patents

método para a preparação de ticagrelor, e, composto

Info

Publication number
BR112015022692A2
BR112015022692A2 BR112015022692A BR112015022692A BR112015022692A2 BR 112015022692 A2 BR112015022692 A2 BR 112015022692A2 BR 112015022692 A BR112015022692 A BR 112015022692A BR 112015022692 A BR112015022692 A BR 112015022692A BR 112015022692 A2 BR112015022692 A2 BR 112015022692A2
Authority
BR
Brazil
Prior art keywords
ticagrelor
preparation
compound
pyrimidine
formula
Prior art date
Application number
BR112015022692A
Other languages
English (en)
Portuguese (pt)
Inventor
Obadalova Iva
Strelec Ivo
Riha Jaroslav
Krampera Vaclav
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of BR112015022692A2 publication Critical patent/BR112015022692A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR112015022692A 2013-03-14 2014-03-14 método para a preparação de ticagrelor, e, composto BR112015022692A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2013-189A CZ307217B6 (cs) 2013-03-14 2013-03-14 Zlepšený způsob výroby a nové intermediáty syntézy ticagreloru
PCT/CZ2014/000028 WO2014139489A1 (en) 2013-03-14 2014-03-14 Method for the preparation of ticagrelor and intermediates suitable therefore

Publications (1)

Publication Number Publication Date
BR112015022692A2 true BR112015022692A2 (pt) 2017-07-18

Family

ID=50478119

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022692A BR112015022692A2 (pt) 2013-03-14 2014-03-14 método para a preparação de ticagrelor, e, composto

Country Status (3)

Country Link
BR (1) BR112015022692A2 (cs)
CZ (1) CZ307217B6 (cs)
WO (1) WO2014139489A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2013866A3 (cs) * 2013-11-08 2015-05-20 Zentiva, K.S. Způsob výroby a nová krystalická forma intermediátu syntézy ticagreloru
DK3398951T3 (da) * 2015-12-31 2021-07-12 Shanghai Pharmaceuticals Holding Co Ltd Salt af quinolonforbindelse, polymorfer deraf, fremgangsmåde til fremstilling deraf, sammensætning og anvendelser
CN115160320B (zh) * 2022-06-27 2024-05-07 南通常佑药业科技有限公司 一种手性嘧啶并三唑类替格瑞洛的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
GB0013488D0 (en) 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
CN102311437A (zh) * 2010-07-01 2012-01-11 北京迈劲医药科技有限公司 一种抗血小板凝集药替卡格雷的制备方法
US9056838B2 (en) * 2011-04-06 2015-06-16 Teva Pharmaceutical Industries Ltd. Intermediates and processes for preparing Ticagrelor
IN2014KN01491A (cs) * 2011-12-23 2015-10-23 Lek Pharmaceuticals
EP2607355A1 (en) * 2011-12-23 2013-06-26 LEK Pharmaceuticals d.d. Synthesis of triazolopyrimidine compounds

Also Published As

Publication number Publication date
CZ2013189A3 (cs) 2014-09-24
WO2014139489A1 (en) 2014-09-18
CZ307217B6 (cs) 2018-04-04

Similar Documents

Publication Publication Date Title
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
CL2013000077A1 (es) Uso de compuestos derivados de ribosas 1’ sustituidas que comprenden nucleobases de pirrolo[1,2-f][1,2,4]triazina para tratar infecciones por paramyxoviridae; compuestos derivados de ribosas 1’ sustituidas que comprenden nucleobases de pirrolo[1,2-f][1,2,4]triazina; y composicion farmaceutica que los comprende.
CR20130247A (es) Compuestos tricíclicos de la pi3k y métodos de uso
DOP2015000227A (es) Virus de la enfermedad de newcastle y usos de los mismos
CL2008002397A1 (es) Compuestos derivados de imidazoles biciclicos fusionados; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar neoplasia benigna o maligna.
BR112015025347A2 (pt) 2-acetil-nafto [2-3-b] furan-4,9-diona para uso no tratamento do câncer
BR112015005301A2 (pt) composições cosméticas biofotônicas
BR112013018402A2 (pt) sistema de bio-refinaria, componentes para o mesmo, processos de uso, e produtos derivados do mesmo
IN2014DN10274A (cs)
CO7240372A2 (es) Formulaciones farmacéuticas tópicas no acuosas
BR112016002101A2 (pt) propante, e, métodos de fabricação e formação de um propante
BR112015025709A2 (pt) monoterapia com gla para uso em tratamento de câncer
BR112012023660A2 (pt) novos métodos para direcionar células-tronco cancerosas
BR112015014438A2 (pt) composto, composição farmacêutica e uso de um composto
UY37015A (es) Inhibidores de la tirosina quinasa de bruton y métodos de su uso
BR112018000187A2 (pt) composto, composição, método, e, uso de um composto ou composição
BR112015026388A2 (pt) métodos e composições para cicatrização de feridas
BR112015023493A2 (pt) método para tratamento de um tumor, método para identificar um sujeito, método para a seleção de um tratamento, e, kit
BR112015022692A2 (pt) método para a preparação de ticagrelor, e, composto
BR112017024609A2 (pt) sistemas, métodos, e dispositivos para compartilhamento e coincidência de informações
BR112016007062A2 (pt) variantes de protoxina-ii e métodos de uso
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
CR11755A (es) Dronedarona para la prevencion de la cardioversion
BR112015029759A2 (pt) preparação de partículas secas que compreendem mentol
BR112012028506A2 (pt) "composições que compreenden extratos de abrótano ( artemisia abrotanum) e um composto de amina"

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2505 DE 08-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.